跳至主要内容
临床试验/IRCT20240117060720N1
IRCT20240117060720N1招募中2 期

Comparison of response to treatment and outcome between triple therapy (colistin + meropenem + ampicillin-sulbactam) and dual therapy (colistin + ampicillin-sulbactam) in patients with carbapenem-resistant Acinetobacter infection admitted to ICU; A randomized controlled trial

Gonabad University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Consent of the patient (in case of unconsciousness, his/her companion) to conduct the study
  • ICU admission
  • Probable or definite infection with ventilator-associated pneumonia or hospital-acquired pneumonia or urosepsis or blood infection of any origin
  • Age 18 years or above
  • Report of Acinetobacter in the culture from the site of infection
  • Acinetobacter resistance to carbapenem

排除标准

  • 未提供

研究者

发起方
Gonabad University of Medical Sciences

相似试验

Efficacy of regimens with and without meropenem in... | 临床试验